Iron Sucrose Accelerates Early Atherogenesis by Increasing Superoxide Production and Upregulating Adhesion Molecules in CKD
High-dose intravenous iron supplementation is associated with adverse cardiovascular outcomes in patients with CKD, but the underlying mechanism is unknown. Our study investigated the causative role of iron sucrose in leukocyte-endothelium interactions, an index of early atherogenesis, and subsequen...
Saved in:
Published in | Journal of the American Society of Nephrology Vol. 25; no. 11; pp. 2596 - 2606 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society of Nephrology
01.11.2014
|
Subjects | |
Online Access | Get full text |
ISSN | 1046-6673 1533-3450 1533-3450 |
DOI | 10.1681/ASN.2013080838 |
Cover
Loading…
Abstract | High-dose intravenous iron supplementation is associated with adverse cardiovascular outcomes in patients with CKD, but the underlying mechanism is unknown. Our study investigated the causative role of iron sucrose in leukocyte-endothelium interactions, an index of early atherogenesis, and subsequent atherosclerosis in the mouse remnant kidney model. We found that expression levels of intracellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) and adhesion of U937 cells increased in iron-treated human aortic endothelial cells through upregulated NADPH oxidase (NOx) and NF-κB signaling. We then measured mononuclear-endothelial adhesion and atherosclerotic lesions of the proximal aorta in male C57BL/6 mice with subtotal nephrectomy, male apolipoprotein E-deficient (ApoE(-/-)) mice with uninephrectomy, and sham-operated mice subjected to saline or parenteral iron loading. Iron sucrose significantly increased tissue superoxide production, expression of tissue cell adhesion molecules, and endothelial adhesiveness in mice with subtotal nephrectomy. Moreover, iron sucrose exacerbated atherosclerosis in the aorta of ApoE(-/-) mice with uninephrectomy. In patients with CKD, intravenous iron sucrose increased circulating mononuclear superoxide production, expression of soluble adhesion molecules, and mononuclear-endothelial adhesion compared with healthy subjects or untreated patients. In summary, iron sucrose aggravated endothelial dysfunction through NOx/NF-κB/CAM signaling, increased mononuclear-endothelial adhesion, and exacerbated atherosclerosis in mice with remnant kidneys. These results suggest a novel causative role for therapeutic iron in cardiovascular complications in patients with CKD. |
---|---|
AbstractList | High-dose intravenous iron supplementation is associated with adverse cardiovascular outcomes in patients with CKD, but the underlying mechanism is unknown. Our study investigated the causative role of iron sucrose in leukocyte–endothelium interactions, an index of early atherogenesis, and subsequent atherosclerosis in the mouse remnant kidney model. We found that expression levels of intracellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) and adhesion of U937 cells increased in iron-treated human aortic endothelial cells through upregulated NADPH oxidase (NOx) and NF-
κ
B signaling. We then measured mononuclear–endothelial adhesion and atherosclerotic lesions of the proximal aorta in male C57BL/6 mice with subtotal nephrectomy, male apolipoprotein E–deficient (ApoE
−/−
) mice with uninephrectomy, and sham-operated mice subjected to saline or parenteral iron loading. Iron sucrose significantly increased tissue superoxide production, expression of tissue cell adhesion molecules, and endothelial adhesiveness in mice with subtotal nephrectomy. Moreover, iron sucrose exacerbated atherosclerosis in the aorta of ApoE
−/−
mice with uninephrectomy. In patients with CKD, intravenous iron sucrose increased circulating mononuclear superoxide production, expression of soluble adhesion molecules, and mononuclear–endothelial adhesion compared with healthy subjects or untreated patients. In summary, iron sucrose aggravated endothelial dysfunction through NOx/NF-
κ
B/CAM signaling, increased mononuclear–endothelial adhesion, and exacerbated atherosclerosis in mice with remnant kidneys. These results suggest a novel causative role for therapeutic iron in cardiovascular complications in patients with CKD. High-dose intravenous iron supplementation is associated with adverse cardiovascular outcomes in patients with CKD, but the underlying mechanism is unknown. Our study investigated the causative role of iron sucrose in leukocyte-endothelium interactions, an index of early atherogenesis, and subsequent atherosclerosis in the mouse remnant kidney model. We found that expression levels of intracellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) and adhesion of U937 cells increased in iron-treated human aortic endothelial cells through upregulated NADPH oxidase (NOx) and NF-κB signaling. We then measured mononuclear-endothelial adhesion and atherosclerotic lesions of the proximal aorta in male C57BL/6 mice with subtotal nephrectomy, male apolipoprotein E-deficient (ApoE(-/-)) mice with uninephrectomy, and sham-operated mice subjected to saline or parenteral iron loading. Iron sucrose significantly increased tissue superoxide production, expression of tissue cell adhesion molecules, and endothelial adhesiveness in mice with subtotal nephrectomy. Moreover, iron sucrose exacerbated atherosclerosis in the aorta of ApoE(-/-) mice with uninephrectomy. In patients with CKD, intravenous iron sucrose increased circulating mononuclear superoxide production, expression of soluble adhesion molecules, and mononuclear-endothelial adhesion compared with healthy subjects or untreated patients. In summary, iron sucrose aggravated endothelial dysfunction through NOx/NF-κB/CAM signaling, increased mononuclear-endothelial adhesion, and exacerbated atherosclerosis in mice with remnant kidneys. These results suggest a novel causative role for therapeutic iron in cardiovascular complications in patients with CKD.High-dose intravenous iron supplementation is associated with adverse cardiovascular outcomes in patients with CKD, but the underlying mechanism is unknown. Our study investigated the causative role of iron sucrose in leukocyte-endothelium interactions, an index of early atherogenesis, and subsequent atherosclerosis in the mouse remnant kidney model. We found that expression levels of intracellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) and adhesion of U937 cells increased in iron-treated human aortic endothelial cells through upregulated NADPH oxidase (NOx) and NF-κB signaling. We then measured mononuclear-endothelial adhesion and atherosclerotic lesions of the proximal aorta in male C57BL/6 mice with subtotal nephrectomy, male apolipoprotein E-deficient (ApoE(-/-)) mice with uninephrectomy, and sham-operated mice subjected to saline or parenteral iron loading. Iron sucrose significantly increased tissue superoxide production, expression of tissue cell adhesion molecules, and endothelial adhesiveness in mice with subtotal nephrectomy. Moreover, iron sucrose exacerbated atherosclerosis in the aorta of ApoE(-/-) mice with uninephrectomy. In patients with CKD, intravenous iron sucrose increased circulating mononuclear superoxide production, expression of soluble adhesion molecules, and mononuclear-endothelial adhesion compared with healthy subjects or untreated patients. In summary, iron sucrose aggravated endothelial dysfunction through NOx/NF-κB/CAM signaling, increased mononuclear-endothelial adhesion, and exacerbated atherosclerosis in mice with remnant kidneys. These results suggest a novel causative role for therapeutic iron in cardiovascular complications in patients with CKD. High-dose intravenous iron supplementation is associated with adverse cardiovascular outcomes in patients with CKD, but the underlying mechanism is unknown. Our study investigated the causative role of iron sucrose in leukocyte-endothelium interactions, an index of early atherogenesis, and subsequent atherosclerosis in the mouse remnant kidney model. We found that expression levels of intracellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) and adhesion of U937 cells increased in iron-treated human aortic endothelial cells through upregulated NADPH oxidase (NOx) and NF-κB signaling. We then measured mononuclear-endothelial adhesion and atherosclerotic lesions of the proximal aorta in male C57BL/6 mice with subtotal nephrectomy, male apolipoprotein E-deficient (ApoE(-/-)) mice with uninephrectomy, and sham-operated mice subjected to saline or parenteral iron loading. Iron sucrose significantly increased tissue superoxide production, expression of tissue cell adhesion molecules, and endothelial adhesiveness in mice with subtotal nephrectomy. Moreover, iron sucrose exacerbated atherosclerosis in the aorta of ApoE(-/-) mice with uninephrectomy. In patients with CKD, intravenous iron sucrose increased circulating mononuclear superoxide production, expression of soluble adhesion molecules, and mononuclear-endothelial adhesion compared with healthy subjects or untreated patients. In summary, iron sucrose aggravated endothelial dysfunction through NOx/NF-κB/CAM signaling, increased mononuclear-endothelial adhesion, and exacerbated atherosclerosis in mice with remnant kidneys. These results suggest a novel causative role for therapeutic iron in cardiovascular complications in patients with CKD. |
Author | Lee, Tzong-Shyuan Tarng, Der-Cherng Kuo, Ko-Lin Hung, Szu-Chun |
Author_xml | – sequence: 1 givenname: Ko-Lin surname: Kuo fullname: Kuo, Ko-Lin – sequence: 2 givenname: Szu-Chun surname: Hung fullname: Hung, Szu-Chun – sequence: 3 givenname: Tzong-Shyuan surname: Lee fullname: Lee, Tzong-Shyuan – sequence: 4 givenname: Der-Cherng surname: Tarng fullname: Tarng, Der-Cherng |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24722448$$D View this record in MEDLINE/PubMed |
BookMark | eNp1Uctq3DAUFSGleXWbZdGyG0_1smxvAmaatEPTtJBkLWT5ekZFI00lu2Toz1dDXm0gq3vhvOCcI7TvgweETimZUVnTj-311YwRyklNal7voUNacl5wUZL9_BMhCykrfoCOUvpJCC1ZVb1FB0xUjAlRH6I_ixg8vp5MDAlwaww4iHqEhM91dFvcjiuIYQkekk242-KFNxF0sn6ZVZuM3dke8I8Y-smMNntp3-PbTYTl5PS4o7X9Kosz8i04MJPL3tbj-ddPJ-jNoF2Cdw_3GN1enN_MvxSX3z8v5u1lYUQpx0KUPeWSGM7NwJqmqQ0AMXVT9dToPv_dwJlhRGreEWqaAXTDddOJrusoA8mP0dm972bq1tAb8GPUTm2iXeu4VUFb9T_i7Uotw28lGBUlI9ngw4NBDL8mSKNa25SbctpDmJKikjacVpLWmfr-36ynkMfGM0HcE3aNpwiDMnbUu-ZytHWKErUbVuVh1fOwWTZ7IXt0fkXwFwgNp20 |
CitedBy_id | crossref_primary_10_3390_ijms25073745 crossref_primary_10_1371_journal_pone_0292646 crossref_primary_10_1155_2017_9035193 crossref_primary_10_3346_jkms_2017_32_2_249 crossref_primary_10_3390_ph11040111 crossref_primary_10_1136_bmjopen_2021_059546 crossref_primary_10_3324_haematol_2020_250803 crossref_primary_10_1093_ckj_sfv142 crossref_primary_10_3390_pharmaceutics15061714 crossref_primary_10_1186_s12882_020_02209_6 crossref_primary_10_1016_j_heliyon_2024_e29164 crossref_primary_10_1097_JCMA_0000000000000725 crossref_primary_10_3390_nu11102424 crossref_primary_10_1089_ars_2020_8167 crossref_primary_10_1155_2017_7543973 crossref_primary_10_1093_ndt_gfv096 crossref_primary_10_1007_s00467_018_4005_4 crossref_primary_10_1038_s41598_022_10717_8 crossref_primary_10_1016_j_bbalip_2021_159004 crossref_primary_10_3389_fcell_2021_799499 crossref_primary_10_1038_s41598_022_05200_3 crossref_primary_10_3390_ijms22115448 crossref_primary_10_1111_petr_13493 crossref_primary_10_1186_s12882_019_1506_8 crossref_primary_10_1080_10408398_2021_1914542 crossref_primary_10_1111_nyas_13461 crossref_primary_10_1038_labinvest_2017_11 crossref_primary_10_1093_cvr_cvab317 crossref_primary_10_1016_j_kint_2015_11_020 crossref_primary_10_1161_CIRCULATIONAHA_121_054271 crossref_primary_10_1016_j_ijcard_2015_03_327 crossref_primary_10_1007_s12011_019_01733_3 crossref_primary_10_1016_j_mam_2020_100862 crossref_primary_10_1093_ndt_gfv085 crossref_primary_10_1007_s12639_023_01603_9 crossref_primary_10_1039_C9TB00002J crossref_primary_10_1016_j_blre_2015_07_006 crossref_primary_10_1016_j_numecd_2020_12_018 crossref_primary_10_1007_s10238_015_0377_y crossref_primary_10_1159_000487368 crossref_primary_10_3390_toxins12040237 crossref_primary_10_18632_oncotarget_17327 crossref_primary_10_1093_ckj_sfaa212 crossref_primary_10_1111_1744_9987_12322 crossref_primary_10_3390_antiox8100498 crossref_primary_10_1152_ajpheart_00076_2019 crossref_primary_10_3390_molecules27165100 crossref_primary_10_1016_j_kint_2015_10_002 crossref_primary_10_1186_s12882_018_1159_z crossref_primary_10_1016_j_bbrc_2015_08_032 crossref_primary_10_1080_14740338_2018_1400009 crossref_primary_10_1111_cts_12443 crossref_primary_10_1093_ndt_gfw045 crossref_primary_10_3390_ijms232416016 crossref_primary_10_1016_j_jacbts_2019_08_009 crossref_primary_10_1096_fj_201802724RR crossref_primary_10_1007_s12325_022_02242_x crossref_primary_10_1161_ATVBAHA_119_312705 crossref_primary_10_1016_j_semnephrol_2016_02_005 crossref_primary_10_1111_hdi_12542 crossref_primary_10_1681_ASN_2015010052 crossref_primary_10_1186_s41100_018_0195_2 crossref_primary_10_3390_nu15214658 |
Cites_doi | 10.1681/ASN.2006080856 10.1097/01.ASN.0000128371.33195.7B 10.1161/ATVBAHA.108.183210 10.1053/j.ajkd.2004.12.012 10.1681/ASN.V125973 10.1371/journal.pone.0050295 10.1385/BTER:96:1-3:109 10.1258/ebm.2011.010298 10.1038/sj.bjp.0704458 10.1161/01.ATV.0000145016.69181.fa 10.1161/01.CIR.0000035250.66458.67 10.1097/01.ASN.0000045048.71975.FC 10.1016/j.bbamcr.2008.01.004 10.1159/000110895 10.1161/01.ATV.0000124892.90999.cb 10.1161/01.CIR.86.3.803 10.1159/000334939 10.1016/S0140-6736(97)09032-6 10.1016/j.ijcard.2006.11.012 10.1111/j.1523-1755.2004.00580.x 10.1093/ndt/gfl341 10.1074/jbc.271.35.21177 10.1097/01.ASN.0000128009.69594.BE 10.1053/ajkd.2002.33917 10.1111/j.1523-1755.2004.00716.x 10.1681/ASN.2004060495 10.1681/ASN.2005040423 10.3109/10715769509065267 10.1093/ndt/15.10.1624 10.1097/01.ASN.0000088024.72216.2E 10.1126/science.1411543 10.1681/ASN.V133734 10.1074/jbc.M110.166686 10.1038/41493 10.1161/01.CIR.96.12.4219 10.1172/JCI118661 10.1172/JCI7664 10.1161/01.CIR.99.9.1222 10.1161/01.ATV.20.10.2175 10.1093/ndt/17.3.435 10.1681/ASN.2007101084 10.1172/JCI14453 10.1046/j.1365-2362.2002.0320s1009.x 10.1681/ASN.2004121039 10.1681/ASN.V113530 10.1161/01.CIR.96.10.3300 10.1016/S0140-6736(81)92463-6 10.1046/j.1523-1755.2002.00637.x |
ContentType | Journal Article |
Copyright | Copyright © 2014 by the American Society of Nephrology. Copyright © 2014 by the American Society of Nephrology 2014 |
Copyright_xml | – notice: Copyright © 2014 by the American Society of Nephrology. – notice: Copyright © 2014 by the American Society of Nephrology 2014 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1681/ASN.2013080838 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1533-3450 |
EndPage | 2606 |
ExternalDocumentID | PMC4214520 24722448 10_1681_ASN_2013080838 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .55 .GJ 0R~ 18M 29L 2WC 34G 39C 53G 5GY 5RE 5VS 6PF AAQQT AAUIN AAWTL AAYXX ABBLC ABJNI ABOCM ABXYN ACGFO ACLDA ACZKN ADBBV AENEX AFEXH AFFNX AFNMH AHOMT AHQVU ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW BYPQX CITATION CS3 DIK DU5 E3Z EBS EJD ERAAH F5P GX1 H13 HYE HZ~ K-O KQ8 O9- OK1 OVD P0W P2P RHI RPM TEORI TNP TR2 W8F X7M XVB YFH ZGI CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c456t-45d1360c33cf29998cee0c897d1cadee0bf32c206a3b01c9fea93a9b4bbb12e63 |
ISSN | 1046-6673 1533-3450 |
IngestDate | Thu Aug 21 14:32:00 EDT 2025 Thu Jul 10 23:40:57 EDT 2025 Mon Jul 21 06:08:13 EDT 2025 Tue Jul 01 04:34:33 EDT 2025 Thu Apr 24 23:10:06 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
License | Copyright © 2014 by the American Society of Nephrology. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c456t-45d1360c33cf29998cee0c897d1cadee0bf32c206a3b01c9fea93a9b4bbb12e63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://jasn.asnjournals.org/content/jnephrol/25/11/2596.full.pdf |
PMID | 24722448 |
PQID | 1619317618 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4214520 proquest_miscellaneous_1619317618 pubmed_primary_24722448 crossref_citationtrail_10_1681_ASN_2013080838 crossref_primary_10_1681_ASN_2013080838 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-11-01 |
PublicationDateYYYYMMDD | 2014-11-01 |
PublicationDate_xml | – month: 11 year: 2014 text: 2014-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of the American Society of Nephrology |
PublicationTitleAlternate | J Am Soc Nephrol |
PublicationYear | 2014 |
Publisher | American Society of Nephrology |
Publisher_xml | – name: American Society of Nephrology |
References | Stenvinkel (R42-23-20230208) 2002; 62 Chen (R29-23-20230208) 2004; 24 Li (R30-23-20230208) 2009; 29 Papayianni (R43-23-20230208) 2002; 17 Henle (R16-23-20230208) 1996; 271 Lim (R11-23-20230208) 2004; 65 Kiechl (R19-23-20230208) 1997; 96 Hörl (R2-23-20230208) 2007; 18 Kim (R32-23-20230208) 2008; 1783 Kurtoglu (R39-23-20230208) 2003; 96 Papagianni (R45-23-20230208) 2008; 28 Salonen (R18-23-20230208) 1992; 86 Bro (R36-23-20230208) 2004; 15 Carlini (R25-23-20230208) 2006; 21 Kuo (R13-23-20230208) 2008; 19 Zager (R24-23-20230208) 2002; 40 DiDonato (R31-23-20230208) 1997; 388 Hwang (R41-23-20230208) 1997; 96 Feldman (R22-23-20230208) 2002; 13 Kamanna (R26-23-20230208) 2012; 35 Stadler (R21-23-20230208) 2004; 24 Lee (R9-23-20230208) 1999; 99 Rooyakkers (R4-23-20230208) 2002; 32 Bro (R35-23-20230208) 2003; 14 Pang (R8-23-20230208) 1996; 97 Stenvinkel (R44-23-20230208) 2000; 15 Besarab (R3-23-20230208) 2000; 11 Zager (R14-23-20230208) 2004; 66 Ito (R28-23-20230208) 2010; 285 Evans (R20-23-20230208) 1995; 23 Wang (R46-23-20230208) 2005; 45 Kuo (R6-23-20230208) 2012; 7 Yin (R47-23-20230208) 2007; 121 Chen (R27-23-20230208) 2002; 135 Buzello (R34-23-20230208) 2003; 14 Chien (R15-23-20230208) 2001; 12 Massy (R37-23-20230208) 2005; 16 Parfrey (R1-23-20230208) 2005; 16 Sullivan (R17-23-20230208) 1981; 1 Kirk (R10-23-20230208) 2001; 107 Drüeke (R5-23-20230208) 2002; 106 Griendling (R12-23-20230208) 2000; 20 Griendling (R38-23-20230208) 2001; 108 Zhang (R33-23-20230208) 1992; 258 Feldman (R23-23-20230208) 2004; 15 Ridker (R40-23-20230208) 1998; 351 Kalantar-Zadeh (R7-23-20230208) 2005; 16 Vu’o’ng Lê (R48-23-20230208) 2011; 236 8636399 - J Clin Invest. 1996 May 15;97(10):2204-12 8702888 - J Biol Chem. 1996 Aug 30;271(35):21177-86 12538731 - J Am Soc Nephrol. 2003 Feb;14(2):311-6 11031201 - Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2175-83 11413162 - J Clin Invest. 2001 Jun;107(12):1545-53 15563564 - J Am Soc Nephrol. 2005 Jan;16(1):109-16 17229908 - J Am Soc Nephrol. 2007 Feb;18(2):382-93 10703677 - J Am Soc Nephrol. 2000 Mar;11(3):530-8 21685238 - Exp Biol Med (Maywood). 2011 Jul;236(7):790-9 6112609 - Lancet. 1981 Jun 13;1(8233):1293-4 14716089 - Biol Trace Elem Res. 2003 Winter;96(1-3):109-15 10069791 - Circulation. 1999 Mar 9;99(9):1222-9 11007832 - Nephrol Dial Transplant. 2000 Oct;15(10):1624-30 22212390 - Am J Nephrol. 2012;35(2):114-9 16033854 - J Am Soc Nephrol. 2005 Oct;16(10):3070-80 9416885 - Circulation. 1997 Dec 16;96(12):4219-25 15153560 - J Am Soc Nephrol. 2004 Jun;15(6):1495-503 15001454 - Arterioscler Thromb Vasc Biol. 2004 May;24(5):949-54 12390950 - Circulation. 2002 Oct 22;106(17):2212-7 11856779 - J Am Soc Nephrol. 2002 Mar;13(3):734-44 12087566 - Am J Kidney Dis. 2002 Jul;40(1):90-103 9439492 - Lancet. 1998 Jan 10;351(9096):88-92 17188380 - Int J Cardiol. 2007 Oct 18;121(3):276-83 23227165 - PLoS One. 2012;7(12):e50295 18495964 - J Am Soc Nephrol. 2008 Sep;19(9):1817-26 19251588 - Arterioscler Thromb Vasc Biol. 2009 May;29(5):732-8 16957011 - Nephrol Dial Transplant. 2006 Nov;21(11):3055-61 17989499 - Am J Nephrol. 2008;28(2):265-74 9396420 - Circulation. 1997 Nov 18;96(10):3300-7 15806475 - Am J Kidney Dis. 2005 Apr;45(4):715-29 25838213 - Int J Cardiol. 2015 May 6;187:196-7 7581829 - Free Radic Res. 1995 Nov;23(5):465-9 15901766 - J Am Soc Nephrol. 2005 Jul;16(7):2180-9 9252186 - Nature. 1997 Aug 7;388(6642):548-54 15153574 - J Am Soc Nephrol. 2004 Jun;15(6):1623-32 11786478 - Br J Pharmacol. 2002 Jan;135(1):37-47 14514724 - J Am Soc Nephrol. 2003 Oct;14(10):2466-74 1516192 - Circulation. 1992 Sep;86(3):803-11 15374848 - Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):2075-81 11316856 - J Am Soc Nephrol. 2001 May;12(5):973-82 11865089 - Nephrol Dial Transplant. 2002 Mar;17(3):435-41 11714732 - J Clin Invest. 2001 Nov;108(10):1423-4 1411543 - Science. 1992 Oct 16;258(5081):468-71 15200421 - Kidney Int. 2004 Jul;66(1):144-56 15086920 - Kidney Int. 2004 May;65(5):1802-9 20937831 - J Biol Chem. 2010 Dec 10;285(50):38869-75 11886426 - Eur J Clin Invest. 2002 Mar;32 Suppl 1:9-16 18241674 - Biochim Biophys Acta. 2008 May;1783(5):886-95 12371981 - Kidney Int. 2002 Nov;62(5):1791-8 |
References_xml | – volume: 18 start-page: 382 year: 2007 ident: R2-23-20230208 article-title: Clinical aspects of iron use in the anemia of kidney disease. publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2006080856 – volume: 15 start-page: 1495 year: 2004 ident: R36-23-20230208 article-title: Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-E-deficient mice. publication-title: J Am Soc Nephrol doi: 10.1097/01.ASN.0000128371.33195.7B – volume: 29 start-page: 732 year: 2009 ident: R30-23-20230208 article-title: Prolonged exposure to LPS increases iron, heme, and p22phox levels and NADPH oxidase activity in human aortic endothelial cells: Inhibition by desferrioxamine. publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.108.183210 – volume: 45 start-page: 715 year: 2005 ident: R46-23-20230208 article-title: Circulating soluble vascular cell adhesion molecule 1: Relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients. publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2004.12.012 – volume: 12 start-page: 973 year: 2001 ident: R15-23-20230208 article-title: De novo demonstration and co-localization of free-radical production and apoptosis formation in rat kidney subjected to ischemia/reperfusion. publication-title: J Am Soc Nephrol doi: 10.1681/ASN.V125973 – volume: 7 start-page: e50295 year: 2012 ident: R6-23-20230208 article-title: Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients. publication-title: PLoS ONE doi: 10.1371/journal.pone.0050295 – volume: 96 start-page: 109 year: 2003 ident: R39-23-20230208 article-title: Activity of neutrophil NADPH oxidase in iron-deficient anemia. publication-title: Biol Trace Elem Res doi: 10.1385/BTER:96:1-3:109 – volume: 236 start-page: 790 year: 2011 ident: R48-23-20230208 article-title: New rat models of iron sucrose-induced iron overload. publication-title: Exp Biol Med (Maywood doi: 10.1258/ebm.2011.010298 – volume: 135 start-page: 37 year: 2002 ident: R27-23-20230208 article-title: Magnolol attenuates VCAM-1 expression in vitro in TNF-alpha-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits. publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0704458 – volume: 24 start-page: 2075 year: 2004 ident: R29-23-20230208 article-title: Carvedilol inhibits tumor necrosis factor-alpha-induced endothelial transcription factor activation, adhesion molecule expression, and adhesiveness to human mononuclear cells. publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.0000145016.69181.fa – volume: 106 start-page: 2212 year: 2002 ident: R5-23-20230208 article-title: Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. publication-title: Circulation doi: 10.1161/01.CIR.0000035250.66458.67 – volume: 14 start-page: 311 year: 2003 ident: R34-23-20230208 article-title: The apolipoprotein e knockout mouse: A model documenting accelerated atherogenesis in uremia. publication-title: J Am Soc Nephrol doi: 10.1097/01.ASN.0000045048.71975.FC – volume: 1783 start-page: 886 year: 2008 ident: R32-23-20230208 article-title: Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells. publication-title: Biochim Biophys Acta doi: 10.1016/j.bbamcr.2008.01.004 – volume: 28 start-page: 265 year: 2008 ident: R45-23-20230208 article-title: Carotid atherosclerosis and endothelial cell adhesion molecules as predictors of long-term outcome in chronic hemodialysis patients. publication-title: Am J Nephrol doi: 10.1159/000110895 – volume: 24 start-page: 949 year: 2004 ident: R21-23-20230208 article-title: Direct detection and quantification of transition metal ions in human atherosclerotic plaques: Evidence for the presence of elevated levels of iron and copper. publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.0000124892.90999.cb – volume: 86 start-page: 803 year: 1992 ident: R18-23-20230208 article-title: High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. publication-title: Circulation doi: 10.1161/01.CIR.86.3.803 – volume: 35 start-page: 114 year: 2012 ident: R26-23-20230208 article-title: Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion/infiltration. publication-title: Am J Nephrol doi: 10.1159/000334939 – volume: 351 start-page: 88 year: 1998 ident: R40-23-20230208 article-title: Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. publication-title: Lancet doi: 10.1016/S0140-6736(97)09032-6 – volume: 121 start-page: 276 year: 2007 ident: R47-23-20230208 article-title: Increased endothelial monocyte adhesiveness is related to clinical outcomes in chronic heart failure. publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2006.11.012 – volume: 65 start-page: 1802 year: 2004 ident: R11-23-20230208 article-title: The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure. publication-title: Kidney Int doi: 10.1111/j.1523-1755.2004.00580.x – volume: 21 start-page: 3055 year: 2006 ident: R25-23-20230208 article-title: Apoptotic stress pathway activation mediated by iron on endothelial cells in vitro. publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfl341 – volume: 271 start-page: 21177 year: 1996 ident: R16-23-20230208 article-title: Oxidative damage to DNA constituents by iron-mediated fenton reactions. The deoxyguanosine family. publication-title: J Biol Chem doi: 10.1074/jbc.271.35.21177 – volume: 15 start-page: 1623 year: 2004 ident: R23-23-20230208 article-title: Administration of parenteral iron and mortality among hemodialysis patients. publication-title: J Am Soc Nephrol doi: 10.1097/01.ASN.0000128009.69594.BE – volume: 40 start-page: 90 year: 2002 ident: R24-23-20230208 article-title: Parenteral iron formulations: A comparative toxicologic analysis and mechanisms of cell injury. publication-title: Am J Kidney Dis doi: 10.1053/ajkd.2002.33917 – volume: 66 start-page: 144 year: 2004 ident: R14-23-20230208 article-title: Parenteral iron nephrotoxicity: Potential mechanisms and consequences. publication-title: Kidney Int doi: 10.1111/j.1523-1755.2004.00716.x – volume: 16 start-page: 109 year: 2005 ident: R37-23-20230208 article-title: Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2004060495 – volume: 16 start-page: 3070 year: 2005 ident: R7-23-20230208 article-title: Time-dependent associations between iron and mortality in hemodialysis patients. publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2005040423 – volume: 23 start-page: 465 year: 1995 ident: R20-23-20230208 article-title: Metal ion release from mechanically-disrupted human arterial wall. Implications for the development of atherosclerosis. publication-title: Free Radic Res doi: 10.3109/10715769509065267 – volume: 15 start-page: 1624 year: 2000 ident: R44-23-20230208 article-title: Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: Association with malnutrition, inflammation, and cardiovascular disease. publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/15.10.1624 – volume: 14 start-page: 2466 year: 2003 ident: R35-23-20230208 article-title: Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice. publication-title: J Am Soc Nephrol doi: 10.1097/01.ASN.0000088024.72216.2E – volume: 258 start-page: 468 year: 1992 ident: R33-23-20230208 article-title: Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. publication-title: Science doi: 10.1126/science.1411543 – volume: 13 start-page: 734 year: 2002 ident: R22-23-20230208 article-title: Iron administration and clinical outcomes in hemodialysis patients. publication-title: J Am Soc Nephrol doi: 10.1681/ASN.V133734 – volume: 285 start-page: 38869 year: 2010 ident: R28-23-20230208 article-title: Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin. publication-title: J Biol Chem doi: 10.1074/jbc.M110.166686 – volume: 388 start-page: 548 year: 1997 ident: R31-23-20230208 article-title: A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. publication-title: Nature doi: 10.1038/41493 – volume: 96 start-page: 4219 year: 1997 ident: R41-23-20230208 article-title: Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk In Communities (ARIC) study. publication-title: Circulation doi: 10.1161/01.CIR.96.12.4219 – volume: 97 start-page: 2204 year: 1996 ident: R8-23-20230208 article-title: Increased ferritin gene expression in atherosclerotic lesions. publication-title: J Clin Invest doi: 10.1172/JCI118661 – volume: 107 start-page: 1545 year: 2001 ident: R10-23-20230208 article-title: Iron overload diminishes atherosclerosis in apoE-deficient mice. publication-title: J Clin Invest doi: 10.1172/JCI7664 – volume: 99 start-page: 1222 year: 1999 ident: R9-23-20230208 article-title: Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. publication-title: Circulation doi: 10.1161/01.CIR.99.9.1222 – volume: 20 start-page: 2175 year: 2000 ident: R12-23-20230208 article-title: Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.20.10.2175 – volume: 17 start-page: 435 year: 2002 ident: R43-23-20230208 article-title: Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: Association with inflammation, dyslipidaemia, and vascular events. publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/17.3.435 – volume: 19 start-page: 1817 year: 2008 ident: R13-23-20230208 article-title: Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2007101084 – volume: 108 start-page: 1423 year: 2001 ident: R38-23-20230208 article-title: Out, damned dot: Studies of the NADPH oxidase in atherosclerosis. publication-title: J Clin Invest doi: 10.1172/JCI14453 – volume: 32 start-page: 9 year: 2002 ident: R4-23-20230208 article-title: Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. publication-title: Eur J Clin Invest doi: 10.1046/j.1365-2362.2002.0320s1009.x – volume: 16 start-page: 2180 year: 2005 ident: R1-23-20230208 article-title: Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2004121039 – volume: 11 start-page: 530 year: 2000 ident: R3-23-20230208 article-title: Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients. publication-title: J Am Soc Nephrol doi: 10.1681/ASN.V113530 – volume: 96 start-page: 3300 year: 1997 ident: R19-23-20230208 article-title: Body iron stores and the risk of carotid atherosclerosis: Prospective results from the Bruneck study. publication-title: Circulation doi: 10.1161/01.CIR.96.10.3300 – volume: 1 start-page: 1293 year: 1981 ident: R17-23-20230208 article-title: Iron and the sex difference in heart disease risk. publication-title: Lancet doi: 10.1016/S0140-6736(81)92463-6 – volume: 62 start-page: 1791 year: 2002 ident: R42-23-20230208 article-title: Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage? publication-title: Kidney Int doi: 10.1046/j.1523-1755.2002.00637.x – reference: 15001454 - Arterioscler Thromb Vasc Biol. 2004 May;24(5):949-54 – reference: 12390950 - Circulation. 2002 Oct 22;106(17):2212-7 – reference: 6112609 - Lancet. 1981 Jun 13;1(8233):1293-4 – reference: 15806475 - Am J Kidney Dis. 2005 Apr;45(4):715-29 – reference: 18241674 - Biochim Biophys Acta. 2008 May;1783(5):886-95 – reference: 15153574 - J Am Soc Nephrol. 2004 Jun;15(6):1623-32 – reference: 11413162 - J Clin Invest. 2001 Jun;107(12):1545-53 – reference: 20937831 - J Biol Chem. 2010 Dec 10;285(50):38869-75 – reference: 25838213 - Int J Cardiol. 2015 May 6;187:196-7 – reference: 12087566 - Am J Kidney Dis. 2002 Jul;40(1):90-103 – reference: 11316856 - J Am Soc Nephrol. 2001 May;12(5):973-82 – reference: 11007832 - Nephrol Dial Transplant. 2000 Oct;15(10):1624-30 – reference: 11865089 - Nephrol Dial Transplant. 2002 Mar;17(3):435-41 – reference: 12371981 - Kidney Int. 2002 Nov;62(5):1791-8 – reference: 22212390 - Am J Nephrol. 2012;35(2):114-9 – reference: 14514724 - J Am Soc Nephrol. 2003 Oct;14(10):2466-74 – reference: 11856779 - J Am Soc Nephrol. 2002 Mar;13(3):734-44 – reference: 17188380 - Int J Cardiol. 2007 Oct 18;121(3):276-83 – reference: 17989499 - Am J Nephrol. 2008;28(2):265-74 – reference: 15901766 - J Am Soc Nephrol. 2005 Jul;16(7):2180-9 – reference: 14716089 - Biol Trace Elem Res. 2003 Winter;96(1-3):109-15 – reference: 11031201 - Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2175-83 – reference: 15200421 - Kidney Int. 2004 Jul;66(1):144-56 – reference: 9252186 - Nature. 1997 Aug 7;388(6642):548-54 – reference: 10069791 - Circulation. 1999 Mar 9;99(9):1222-9 – reference: 15563564 - J Am Soc Nephrol. 2005 Jan;16(1):109-16 – reference: 1516192 - Circulation. 1992 Sep;86(3):803-11 – reference: 21685238 - Exp Biol Med (Maywood). 2011 Jul;236(7):790-9 – reference: 1411543 - Science. 1992 Oct 16;258(5081):468-71 – reference: 9439492 - Lancet. 1998 Jan 10;351(9096):88-92 – reference: 15374848 - Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):2075-81 – reference: 8636399 - J Clin Invest. 1996 May 15;97(10):2204-12 – reference: 7581829 - Free Radic Res. 1995 Nov;23(5):465-9 – reference: 15086920 - Kidney Int. 2004 May;65(5):1802-9 – reference: 23227165 - PLoS One. 2012;7(12):e50295 – reference: 18495964 - J Am Soc Nephrol. 2008 Sep;19(9):1817-26 – reference: 16957011 - Nephrol Dial Transplant. 2006 Nov;21(11):3055-61 – reference: 8702888 - J Biol Chem. 1996 Aug 30;271(35):21177-86 – reference: 11786478 - Br J Pharmacol. 2002 Jan;135(1):37-47 – reference: 9416885 - Circulation. 1997 Dec 16;96(12):4219-25 – reference: 11714732 - J Clin Invest. 2001 Nov;108(10):1423-4 – reference: 19251588 - Arterioscler Thromb Vasc Biol. 2009 May;29(5):732-8 – reference: 12538731 - J Am Soc Nephrol. 2003 Feb;14(2):311-6 – reference: 9396420 - Circulation. 1997 Nov 18;96(10):3300-7 – reference: 16033854 - J Am Soc Nephrol. 2005 Oct;16(10):3070-80 – reference: 15153560 - J Am Soc Nephrol. 2004 Jun;15(6):1495-503 – reference: 11886426 - Eur J Clin Invest. 2002 Mar;32 Suppl 1:9-16 – reference: 17229908 - J Am Soc Nephrol. 2007 Feb;18(2):382-93 – reference: 10703677 - J Am Soc Nephrol. 2000 Mar;11(3):530-8 |
SSID | ssj0015277 |
Score | 2.4172475 |
Snippet | High-dose intravenous iron supplementation is associated with adverse cardiovascular outcomes in patients with CKD, but the underlying mechanism is unknown.... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 2596 |
SubjectTerms | Animals Atherosclerosis - chemically induced Atherosclerosis - metabolism Atherosclerosis - pathology Basic Research Cell Adhesion - drug effects Cell Adhesion - physiology Endothelial Cells - cytology Ferric Compounds - metabolism Ferric Compounds - pharmacology Glucaric Acid - metabolism Glucaric Acid - pharmacology Humans Injections, Intravenous Intercellular Adhesion Molecule-1 - metabolism Leukocytes - cytology Leukocytes - metabolism Lipid Peroxidation - drug effects Lipid Peroxidation - physiology Male Mice, Inbred C57BL Monocytes - cytology Monocytes - metabolism NF-kappa B - metabolism Renal Insufficiency, Chronic - chemically induced Renal Insufficiency, Chronic - metabolism Renal Insufficiency, Chronic - pathology Superoxides - metabolism U937 Cells Up-Regulation - physiology Vascular Cell Adhesion Molecule-1 - metabolism |
Title | Iron Sucrose Accelerates Early Atherogenesis by Increasing Superoxide Production and Upregulating Adhesion Molecules in CKD |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24722448 https://www.proquest.com/docview/1619317618 https://pubmed.ncbi.nlm.nih.gov/PMC4214520 |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZZB2MvY_d23YYGgz0EdbIl2_FjSVu6Jc0e6kDejCUrTWBzihNDm_2L_eIdyfKtF-j2YowsK8HfZ-no-JzvIPSZO4oHKQuJVk4hPIBXSvihIq5UifLckM5NVtrZxD-d8u8zb9br_WlFLRUbcSC3d-aV_A-q0Aa46izZf0C2HhQa4BzwhSMgDMcHYfwtB-zWhV7ptCqGhCVEKz-s-8rIFhvjbnWhZ7PlWtuZy0zbiMY7sC60QvjVMtWJUkb0tYpLLi7zsj69SV9MF0r70_q_yjK6JnyrPxwd3WPUthJVsjoiVDslFJCm48EfFcZJO1qR8TJryGW919uCDBfFzXChaLvKLsj54rpoOB0leXnPkcrhHpXbpdh6MhxuU_raky8jjJdCtAfqjjY7Y5ep0hUznfb865X1cW8tDP5ALwyH5xMdzcfATB6UojJdBe7Jj_hkOh7H0fEseoQeu7D1cCsPkP0y5bmmmmf9v6wQKIz_tTt619C5tXu5GYTbsmqi5-iZRQ4fltx6gXoqe4menNmAi1fot6YYthTDLYphQzHcoRgW17ihGG4ohhuKYaAYblMMVxTDNcVgEAwUe42mJ8fR8JTYeh1Eghm-IdxLHeZTyZicg5UTDsAAo3IQBqmjcz0UFXPmSpf6CRPUkeFcJSFLQsGFEI6rfPYG7WSrTO0i7ARMBokSIecpT5NB4iUqUCycCypoSukeItXDjaUVs9c1VX7GelMLYMQARtyAsYe-1P0vSxmXe3t-qrCKYabVn8-STK2KNXSGzY4T-A70eVtiV4_las1VzuFK0EG17qBV3LtXsuXCqLlzXSvApe8e8Lv76Gnz3rxHO5u8UB_AJt6Ij4akfwGEI78n |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Iron+sucrose+accelerates+early+atherogenesis+by+increasing+superoxide+production+and+upregulating+adhesion+molecules+in+CKD&rft.jtitle=Journal+of+the+American+Society+of+Nephrology&rft.au=Kuo%2C+Ko-Lin&rft.au=Hung%2C+Szu-Chun&rft.au=Lee%2C+Tzong-Shyuan&rft.au=Tarng%2C+Der-Cherng&rft.date=2014-11-01&rft.issn=1533-3450&rft.eissn=1533-3450&rft.volume=25&rft.issue=11&rft.spage=2596&rft_id=info:doi/10.1681%2FASN.2013080838&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1046-6673&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1046-6673&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1046-6673&client=summon |